Jack Z Gougoutas

USPTO Granted Patents = 19 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 353(Granted Patents)

Company Filing History:

16 out of 3,685

Bristol-myers Squibb Compnay

Bristol Meyers Squibb Company

patents

Years Active: 2002-2016

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2016-09-27),

2. 8802715 - Crystal forms of saxagliptin and processes for preparing same (2014-08-12),

3. 8513428 - Process for preparing atazanavir bisulfate and novel forms (2013-08-20),

4. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2013-08-06),

5. 8236847 - Crystal forms of saxagliptin and processes for preparing same (2012-08-07),

6. 7943656 - Crystal forms of saxagliptin and processes for preparing same (2011-05-17),

7. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2011-04-26),

8. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same (2011-04-05),

9. 7838678 - Process for preparing atazanavir bisulfate and novel forms (2010-11-23),

10. 7829720 - Process for preparing atazanavir bisulfate and novel forms (2010-11-09),

11. 7381737 - Crystalline forms and process for preparing spiro-hydantoin compounds (2008-06-03),

12. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors (2008-05-20),

13. 7241899 - Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B (2007-07-10),

14. 7153879 - Polymorphs of an epothilone analog (2006-12-26),

15. 6982276 - Polymorphs of an epothilone analog (2006-01-03),

Title: Jack Z Gougoutas: Innovator in Pharmaceutical Crystal Structures

Introduction

Jack Z Gougoutas is a prominent inventor based in Princeton, NJ, known for his substantial contributions to pharmaceutical science. With a total of 19 patents to his name, he has significantly advanced the field of drug formulations, particularly in the realm of diabetes treatment.

Latest Patents

Among Jack's most recent patents is the one focused on the "Crystal structures of SGLT2 inhibitors and processes for preparing same." This invention relates to the development of physical crystal structures of specific compounds, along with pharmaceutical compositions that utilize these structures. Moreover, the invention outlines processes for preparing these crystal forms and methods for treating diseases, such as diabetes, using these innovations.

Additionally, Jack has contributed to the development of "Crystal forms of saxagliptin and processes for preparing same." This patent provides details on various physical crystal structures of saxagliptin, including distinct forms such as the free base monohydrate and different hydrochloric acid salts. These formulations also aim to enhance the efficacy of treatment for patients with diabetes.

Career Highlights

Jack Z Gougoutas has built a distinguished career in the pharmaceutical industry, working with several leading companies, including Bristol Myers Squibb Company and AstraZeneca AB. His expertise in crystal structure development has played a crucial role in advancing therapeutic options for diabetes management.

Collaborations

Throughout his career, Jack has collaborated with esteemed professionals in the field. Notable colleagues include John D DiMarco and Martha Davidovich, whose collective efforts have furthered the innovations in pharmaceutical compositions and delivery systems.

Conclusion

Jack Z Gougoutas's contributions to the field of pharmaceutical sciences are marked by his innovative patents and successful collaborations. His work continues to impact the treatment of diabetes, showcasing the importance of creativity and science in developing effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.